Cargando…
Therapeutic Potential of CKD-504, a Novel Selective Histone Deacetylase 6 Inhibitor, in a Zebrafish Model of Neuromuscular Junction Disorders
The neuromuscular junction (NMJ), which is a synapse for signal transmission from motor neurons to muscle cells, has emerged as an important region because of its association with several peripheral neuropathies. In particular, mutations in GARS that affect the formation of NMJ result in Charcot-Mar...
Autores principales: | Jeong, Hui Su, Kim, Hye Jin, Kim, Deok-Ho, Chung, Ki Wha, Choi, Byung-Ok, Lee, Ji Eun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Molecular and Cellular Biology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9001154/ https://www.ncbi.nlm.nih.gov/pubmed/35356895 http://dx.doi.org/10.14348/molcells.2022.5005 |
Ejemplares similares
-
A novel HDAC6 inhibitor, CKD-504, is effective in treating preclinical models of huntington’s disease
por: Li, Endan, et al.
Publicado: (2023) -
CKD-5, a novel pan-histone deacetylase inhibitor, synergistically enhances the efficacy of sorafenib for hepatocellular carcinoma
por: Chang, Young, et al.
Publicado: (2020) -
A novel histone deacetylase inhibitor, CKD5, has potent anti-cancer effects in glioblastoma
por: Choi, Seung Ah, et al.
Publicado: (2016) -
Zebrafish mutants of the neuromuscular junction: swimming in the gene pool
por: Daikoku, Eriko, et al.
Publicado: (2015) -
Therapeutic potential of CKD-506, a novel selective histone deacetylase 6 inhibitor, in a murine model of rheumatoid arthritis
por: Park, Jin Kyun, et al.
Publicado: (2020)